148 related articles for article (PubMed ID: 17651380)
21. Efficacy of sublingual specific immunotherapy in patients with respiratory allergy to Alternaria alternata: a randomised, assessor-blinded, patient-reported outcome, controlled 3-year trial.
Pozzan M; Milani M
Curr Med Res Opin; 2010 Dec; 26(12):2801-6. PubMed ID: 21050060
[TBL] [Abstract][Full Text] [Related]
22. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
[TBL] [Abstract][Full Text] [Related]
23. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites.
Passalacqua G; Pasquali M; Ariano R; Lombardi C; Giardini A; Baiardini I; Majani G; Falagiani P; Bruno M; Canonica GW
Allergy; 2006 Jul; 61(7):849-54. PubMed ID: 16792583
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
Lizogub VG; Riley DS; Heger M
Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
[TBL] [Abstract][Full Text] [Related]
25. A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients.
Wang H; Lin X; Hao C; Zhang C; Sun B; Zheng J; Chen P; Sheng J; Wu A; Zhong N
Allergy; 2006 Feb; 61(2):191-7. PubMed ID: 16409195
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
[TBL] [Abstract][Full Text] [Related]
27. Advances in upper airway diseases and allergen immunotherapy.
Nelson HS
J Allergy Clin Immunol; 2005 Apr; 115(4):676-84. PubMed ID: 15805984
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma.
Skoner DP; Greos LS; Kim KT; Roach JM; Parsey M; Baumgartner RA
Pediatr Pulmonol; 2005 Dec; 40(6):477-86. PubMed ID: 16193496
[TBL] [Abstract][Full Text] [Related]
29. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study.
Bernardini R; Campodonico P; Burastero S; Azzari C; Novembre E; Pucci N; Massai C; De Martino M; Vierucci A
Curr Med Res Opin; 2006 Aug; 22(8):1515-22. PubMed ID: 16870076
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
[TBL] [Abstract][Full Text] [Related]
31. Double-blind, placebo-controlled study of immunotherapy with Parietaria judaica: clinical efficacy and tolerance.
Ferrer M; Burches E; Peláez A; Muñoz A; Hernández D; Basomba A; Enrique E; Alonso R; Cisteró-Bahima A; Martín S; Rico P; Gandarias B
J Investig Allergol Clin Immunol; 2005; 15(4):283-92. PubMed ID: 16433210
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of efficacy of immunotherapy in children with asthma monosensitized to Alternaria.
Kiliç M; Altintaş DU; Yilmaz M; Bingöl-Karakoç G; Burgut R; Güneşer-Kendirli S
Turk J Pediatr; 2011; 53(3):285-94. PubMed ID: 21980810
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
[TBL] [Abstract][Full Text] [Related]
34. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Pajno GB; Caminiti L; Vita D; Barberio G; Salzano G; Lombardo F; Canonica GW; Passalacqua G
J Allergy Clin Immunol; 2007 Jul; 120(1):164-70. PubMed ID: 17543376
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases.
Moreno C; Cuesta-Herranz J; Fernández-Távora L; Alvarez-Cuesta E;
Clin Exp Allergy; 2004 Apr; 34(4):527-31. PubMed ID: 15080803
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F
J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937
[TBL] [Abstract][Full Text] [Related]
37. Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patients.
Tabar AI; Anda M; Bonifazi F; Bilò MB; Leynadier F; Fuchs T; Ring J; Galvain S; André C
Int Arch Allergy Immunol; 2006; 141(4):369-76. PubMed ID: 16943675
[TBL] [Abstract][Full Text] [Related]
38. Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study.
Nettis E; Colanardi MC; Soccio AL; Marcandrea M; Pinto L; Ferrannini A; Tursi A; Vacca A
Br J Dermatol; 2007 Apr; 156(4):674-81. PubMed ID: 17493066
[TBL] [Abstract][Full Text] [Related]
39. A double-blind, placebo controlled study of Alpare mite D. pteronyssinus immunotherapy in asthmatic patients.
Franco C; Barbadori S; Freshwater LL; Kordash TR
Allergol Immunopathol (Madr); 1995; 23(2):58-66. PubMed ID: 8526168
[TBL] [Abstract][Full Text] [Related]
40. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
